A Double-Blind Randomized Crossover Study of Oral Thalidomide Versus Placebo for Androgen Dependent Prostate Cancer Treated With Intermittent Androgen Ablation
- William D. Figg*
- , Maha H. Hussain
- , James L. Gulley
- , Philip M. Arlen
- , Jeanny B. Aragon-Ching
- , Daniel P. Petrylak
- , Celestia S. Higano
- , Seth M. Steinberg
- , Gurkamal S. Chatta
- , Howard Parnes
- , John J. Wright
- , Oliver Sartor
- , William L. Dahut
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
37
Scopus
citations